Genetic variations in TP53 binding sites are predictors of clinical outcomes in prostate cancer patients.
about
Liposome-mediated transfection of wild-type P53 DNA into human prostate cancer cells is improved by low-frequency ultrasound combined with microbubbles.Association between polymorphisms in TP53 and MDM2 genes and susceptibility to prostate cancerTrps1 regulates biliary epithelial-mesenchymal transition and has roles during biliary fibrosis in liver grafts: a preliminary studyGenetic variants in ultraconserved regions associate with prostate cancer recurrence and survivalEpigenetic alterations in TRAMP mice: epigenome DNA methylation profiling using MeDIP-seq.A common regulatory variant in SLC35B4 influences the recurrence and survival of prostate cancer.
P2860
Genetic variations in TP53 binding sites are predictors of clinical outcomes in prostate cancer patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Genetic variations in TP53 bin ...... s in prostate cancer patients.
@en
Genetic variations in TP53 bin ...... s in prostate cancer patients.
@nl
type
label
Genetic variations in TP53 bin ...... s in prostate cancer patients.
@en
Genetic variations in TP53 bin ...... s in prostate cancer patients.
@nl
prefLabel
Genetic variations in TP53 bin ...... s in prostate cancer patients.
@en
Genetic variations in TP53 bin ...... s in prostate cancer patients.
@nl
P2093
P2860
P1476
Genetic variations in TP53 bin ...... s in prostate cancer patients.
@en
P2093
Chia-Cheng Yu
Shu-Pin Huang
Ta-Yuan Chang
Te-Ling Lu
Victor C Lin
Yung-Chin Lee
P2860
P2888
P304
P356
10.1007/S00204-014-1196-8
P577
2014-01-22T00:00:00Z